CFO
ALMIRALL S.A.
Equibles does not estimate personal net worth.
John Garay is recorded as CFO at ALMIRALL S.A.. John Garay has spoken on 1 earnings call across 1 company, most recently for ALMIRALL S.A. on July 24, 2026. ALMIRALL S.A. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Net sales for the first half reached 603 million euros, a 7.5% growth year-on-year, and a 10% growth in the last 12 months, which is in line with providing net sales guidance rates.”
ALMIRALL S.A.
CFO
Transcript header (unverified)
ALMIRALL S.A.
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
H1 2026 Financial Results
ALMIRALL S.A.
